Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside
Justin C. Laracy, Mini Kamboj, Santosha A. Vardhana
Current Opinion in Infectious Diseases (2022) Vol. 35, Iss. 4, pp. 271-279
Open Access | Times Cited: 23

Showing 23 citing articles:

Converging Evidence of Similar Symptomatology of ME/CFS and PASC Indicating Multisystemic Dyshomeostasis
David F Marks
Biomedicines (2023) Vol. 11, Iss. 1, pp. 180-180
Open Access | Times Cited: 14
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report
Anna Gidari, Samuele Sabbatini, Elisabetta Schiaroli, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1577-1577
Open Access | Times Cited: 13
Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID‐19 infection at an ambulatory cancer center
Eduardo Sanchez, Elizabeth M. Krantz, Leah M. Yoke, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 3
Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation During the Omicron Wave: A Single-Center Study
Panpan Zhu, Luxin Yang, Lizhen Liu, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 3
Successful Treatment of Persistent Symptomatic Coronavirus Disease 19 Infection With Extended-Duration Nirmatrelvir-Ritonavir Among Outpatients With Hematologic Cancer
Catherine Liu, Leah H Yoke, Pooja Bhattacharyya, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 6
Open Access | Times Cited: 9
Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases
Chiho Furuya, Hajime Yasuda, Makoto Hiki, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients
Sabina Herrera, José María Aguado, Francisco Javier Candel, et al.
Transplantation Reviews (2023) Vol. 37, Iss. 4, pp. 100788-100788
Closed Access | Times Cited: 7
Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early‐stage symptomatic COVID‐19: A real‐life experience
José María Caso, Mario Fernández‐Ruiz, Francisco López‐Medrano, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Open Access | Times Cited: 7
Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Shedding in a Patient With AIDS: Case Report and Review of the Literature
Jillian Peters, Amary Fall, Steven D. Langerman, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 9
Open Access | Times Cited: 11
SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin’s Lymphoma
Rodrigo Villaseñor-Echavarri, Laura Gómez-Romero, Alexandra Martin‐Onraët, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 377-377
Open Access | Times Cited: 5
Updated COVID‐19 clearance time among patients with cancer in the Delta and Omicron waves
Zachary M. Avigan, Rodrigo Paredes, Leora Boussi, et al.
Cancer Medicine (2023) Vol. 12, Iss. 16, pp. 16869-16875
Open Access | Times Cited: 5
Treatment of Persistent Coronavirus Disease 2019 (COVID-19) in a B Cell Acute Lymphoblastic Leukemia Patient with Using Nirmatrelvir/Ritonavir Extended Course: A Case Report
Hassan Almarhabi, Aisha Alharbi, Mai Alalawi, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 10, pp. 102526-102526
Open Access | Times Cited: 1
Long Neuro-COVID-19: Current Mechanistic Views and Therapeutic Perspectives
Anny Slama‐Schwok, Julien Henri
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1081-1081
Open Access | Times Cited: 1
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity
Alberto Moreno, Kelly E. Manning, Maryam I. Azeem, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Lessons learned: use of WGS in real-time investigation of suspected intrahospital SARS-CoV-2 outbreaks
H. Berggreen, Alexander Hesselberg Løvestad, K. Helmersen, et al.
Journal of Hospital Infection (2022) Vol. 131, pp. 81-88
Open Access | Times Cited: 4
A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments
Flavia Sanmartin, Eugenia Magrini, Emanuele Rando, et al.
American Journal of Case Reports (2024) Vol. 25
Open Access
Successful Sequential Treatment From Remdesivir to Molnupiravir for Prolonged COVID-19 in a Patient With Follicular Lymphoma and Renal Pelvic Carcinoma: A Case Report
Takahiro Sato, Kentaro Akata, Kei Yamasaki, et al.
Cureus (2024)
Open Access
Remdesivir-Nirmatrelvir Combination: In Vitro Activity and a Case Report
Anna Gidari, Samuele Sabbatini, Elisabetta Schiaroli, et al.
(2023)
Open Access | Times Cited: 1
Study Protocol of a Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in COVID-19 Patients with Comorbidities
Wang-Da Liu, Hsin‐An Hou, Ko‐Jen Li, et al.
Advances in Therapy (2023) Vol. 41, Iss. 2, pp. 847-856
Closed Access | Times Cited: 1
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity
Alberto Moreno, Kelly E. Manning, Maryam I. Azeem, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity
Mehul S. Suthar, Alberto Moreno, Kelly E. Manning, et al.
Research Square (Research Square) (2023)
Open Access
Liver resection in a patient with persistent positive PCR test for coronavirus disease 2019 (COVID-19): a case report
Akiho Sugita, Fuyuki Inagaki, Nobuyuki Takemura, et al.
Surgical Case Reports (2022) Vol. 8, Iss. 1
Open Access
Reply to Çınar et al. Comment on “Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874”
Ana Căruntu, Constantin Căruntu, Cristian Scheau
Medicina (2022) Vol. 58, Iss. 11, pp. 1576-1576
Open Access
Page 1

Scroll to top